EUR 1.35
(-12.65%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -37.4 Million EUR | -196.24% |
2022 | 38.86 Million EUR | -72.37% |
2021 | 140.65 Million EUR | 207.54% |
2020 | 45.73 Million EUR | 4029.6% |
2019 | 1.1 Million EUR | 197.9% |
2018 | 371.75 Thousand EUR | -59.67% |
2017 | 921.85 Thousand EUR | 15.06% |
2016 | 801.19 Thousand EUR | 231.17% |
2015 | -610.81 Thousand EUR | 11.35% |
2014 | -689 Thousand EUR | 30.42% |
2013 | -990.23 Thousand EUR | -29.61% |
2012 | -763.99 Thousand EUR | -76.11% |
2011 | -433.81 Thousand EUR | -407.68% |
2010 | -85.45 Thousand EUR | 65.99% |
2009 | -251.24 Thousand EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -11.1 Million EUR | 0.0% |
2023 Q4 | -37.4 Million EUR | 0.0% |
2023 FY | -37.4 Million EUR | -196.24% |
2023 Q2 | -17.83 Million EUR | 0.0% |
2022 Q2 | 46.96 Million EUR | 0.0% |
2022 FY | 38.86 Million EUR | -72.37% |
2022 Q4 | -8.09 Million EUR | 0.0% |
2021 FY | 140.65 Million EUR | 207.54% |
2021 Q4 | 42.31 Million EUR | 0.0% |
2021 Q2 | 98.34 Million EUR | 0.0% |
2020 FY | 45.73 Million EUR | 4029.6% |
2020 Q4 | 37.09 Million EUR | 0.0% |
2020 Q2 | 8.63 Million EUR | 0.0% |
2019 FY | 1.1 Million EUR | 197.9% |
2019 Q2 | 595.33 Thousand EUR | 0.0% |
2019 Q4 | 512.32 Thousand EUR | 0.0% |
2018 Q4 | 177.62 Thousand EUR | 0.0% |
2018 Q2 | 194.13 Thousand EUR | 0.0% |
2018 FY | 371.75 Thousand EUR | -59.67% |
2017 Q4 | -144.08 Thousand EUR | 0.0% |
2017 FY | 921.85 Thousand EUR | 15.06% |
2017 Q2 | 1.06 Million EUR | 0.0% |
2016 Q2 | -499.75 Thousand EUR | 0.0% |
2016 Q4 | 1.3 Million EUR | 0.0% |
2016 FY | 801.19 Thousand EUR | 231.17% |
2015 FY | -610.81 Thousand EUR | 11.35% |
2015 Q2 | -101.29 Thousand EUR | 0.0% |
2015 Q4 | -509.51 Thousand EUR | 0.0% |
2014 Q2 | -531.92 Thousand EUR | 0.0% |
2014 FY | -689 Thousand EUR | 30.42% |
2014 Q4 | -157.07 Thousand EUR | 0.0% |
2013 Q1 | -468.21 Thousand EUR | 0.0% |
2013 FY | -990.23 Thousand EUR | -29.61% |
2013 Q4 | -511.29 Thousand EUR | -9.2% |
2013 Q3 | -468.21 Thousand EUR | 2.24% |
2013 Q2 | -478.93 Thousand EUR | -2.29% |
2012 Q4 | -468.21 Thousand EUR | -145.14% |
2012 FY | -763.99 Thousand EUR | -76.11% |
2012 Q1 | -191 Thousand EUR | 0.0% |
2012 Q2 | -191 Thousand EUR | 0.0% |
2012 Q3 | -191 Thousand EUR | 0.0% |
2011 Q1 | -100 Thousand EUR | 0.0% |
2011 Q2 | -100 Thousand EUR | 0.0% |
2011 Q3 | -100 Thousand EUR | 0.0% |
2011 Q4 | -191 Thousand EUR | -91.0% |
2011 FY | -433.81 Thousand EUR | -407.68% |
2010 Q3 | -23.19 Thousand EUR | 0.0% |
2010 Q1 | -23.19 Thousand EUR | 0.0% |
2010 Q2 | -23.19 Thousand EUR | 0.0% |
2010 Q4 | -100 Thousand EUR | -331.08% |
2010 FY | -85.45 Thousand EUR | 65.99% |
2009 Q1 | -62.05 Thousand EUR | 0.0% |
2009 FY | -251.24 Thousand EUR | 0.0% |
2009 Q4 | -23.19 Thousand EUR | 62.61% |
2009 Q3 | -62.05 Thousand EUR | 0.0% |
2009 Q2 | -62.05 Thousand EUR | 0.0% |
2008 Q4 | -62.05 Thousand EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Predilife S.A. | -3.83 Million EUR | -874.088% |
bioMĂ©rieux S.A. | 439.1 Million EUR | 108.518% |
Eurofins Scientific SE | 717 Million EUR | 105.217% |
Lumibird SA | 12.17 Million EUR | 407.295% |